Ovintiv Earnings Calls
| Release date | May 11, 2026 |
| EPS estimate | $1.89 |
| EPS actual | $2.00 |
| EPS Surprise | 5.82% |
| Revenue estimate | 2.383B |
| Revenue actual | 2.532B |
| Revenue Surprise | 6.24% |
| Release date | Feb 23, 2026 |
| EPS estimate | $1.01 |
| EPS actual | $1.39 |
| EPS Surprise | 37.62% |
| Revenue estimate | 1.933B |
| Revenue actual | 2.072B |
| Revenue Surprise | 7.16% |
| Release date | Nov 04, 2025 |
| EPS estimate | $0.95 |
| EPS actual | $1.03 |
| EPS Surprise | 8.65% |
| Revenue estimate | 1.982B |
| Revenue actual | 2.02B |
| Revenue Surprise | 1.91% |
| Release date | Jul 24, 2025 |
| EPS estimate | $1.04 |
| EPS actual | $1.02 |
| EPS Surprise | -1.92% |
| Revenue estimate | 1.904B |
| Revenue actual | 2.318B |
| Revenue Surprise | 21.75% |
Last 4 Quarters for Ovintiv
Below you can see how OVV performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 24, 2025 |
| Price on release | $39.99 |
| EPS estimate | $1.04 |
| EPS actual | $1.02 |
| EPS surprise | -1.92% |
| Date | Price |
|---|---|
| Jul 18, 2025 | $40.05 |
| Jul 21, 2025 | $38.91 |
| Jul 22, 2025 | $39.25 |
| Jul 23, 2025 | $39.47 |
| Jul 24, 2025 | $39.99 |
| Jul 25, 2025 | $41.43 |
| Jul 28, 2025 | $42.91 |
| Jul 29, 2025 | $42.90 |
| Jul 30, 2025 | $42.27 |
| 4 days before | -0.150% |
| 4 days after | 5.70% |
| On release day | 3.60% |
| Change in period | 5.54% |
| Release date | Nov 04, 2025 |
| Price on release | $37.29 |
| EPS estimate | $0.95 |
| EPS actual | $1.03 |
| EPS surprise | 8.65% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $36.90 |
| Oct 30, 2025 | $36.89 |
| Oct 31, 2025 | $37.51 |
| Nov 03, 2025 | $37.54 |
| Nov 04, 2025 | $37.29 |
| Nov 05, 2025 | $36.64 |
| Nov 06, 2025 | $37.56 |
| Nov 07, 2025 | $38.86 |
| Nov 10, 2025 | $38.85 |
| 4 days before | 1.06% |
| 4 days after | 4.18% |
| On release day | -1.74% |
| Change in period | 5.28% |
| Release date | Feb 23, 2026 |
| Price on release | $50.83 |
| EPS estimate | $1.01 |
| EPS actual | $1.39 |
| EPS surprise | 37.62% |
| Date | Price |
|---|---|
| Feb 17, 2026 | $46.08 |
| Feb 18, 2026 | $49.08 |
| Feb 19, 2026 | $50.67 |
| Feb 20, 2026 | $50.58 |
| Feb 23, 2026 | $50.83 |
| Feb 24, 2026 | $50.09 |
| Feb 25, 2026 | $49.33 |
| Feb 26, 2026 | $49.44 |
| Feb 27, 2026 | $50.59 |
| 4 days before | 10.31% |
| 4 days after | -0.472% |
| On release day | -1.46% |
| Change in period | 9.79% |
| Release date | May 11, 2026 |
| Price on release | $59.09 |
| EPS estimate | $1.89 |
| EPS actual | $2.00 |
| EPS surprise | 5.82% |
| Date | Price |
|---|---|
| May 05, 2026 | $63.08 |
| May 06, 2026 | $59.90 |
| May 07, 2026 | $58.29 |
| May 08, 2026 | $57.83 |
| May 11, 2026 | $59.09 |
| May 12, 2026 | $58.09 |
| May 13, 2026 | $57.79 |
| May 14, 2026 | $58.30 |
| May 15, 2026 | $60.00 |
| 4 days before | -6.33% |
| 4 days after | 1.54% |
| On release day | -1.69% |
| Change in period | -4.88% |
Ovintiv Earnings Call Transcript Summary of Q1 2026
Ovintiv reported a strong start to 2026 driven by operational outperformance, portfolio optimization and significant balance sheet improvement. Key operational highlights include high productivity wells in both the Permian and Montney, successful integration of the NuVista assets (with $100M run-rate synergies targeted and early per-well cost savings), and continued roll-out of surfactant treatment (now planned for nearly all Permian wells) and other stacked innovations that have materially improved oil productivity per foot. Financially, Q1 free cash flow was $634 million, cash flow per share beat consensus, capital spend was $605 million (low end of guidance), and the company recorded a $1.2 billion after-tax noncash ceiling test impairment driven by weaker Q1 SEC trailing prices (management does not expect further impairments at current strip). Balance sheet progress: net debt was reduced to less than $3.3 billion (<0.8x leverage) with no long-term maturities before 2030, about $4 billion of liquidity, and expected annualized interest savings of over $80 million. The company reaffirmed 2026 production and capital guidance, noted higher Canadian royalties are reducing reported net volumes but increasing revenue, and emphasized a deliberate, level-loaded capital program (stay-flat plan) while retaining optionality to grow. Management updated its shareholder return framework (previously 50–100% of FCF) to target 50–75% of free cash flow to returns if prices remain elevated (with the ability to move back to >=75% if prices retreat) and intends to prioritize a balance of buybacks and accelerated debt reduction. Overall tone: durable, de-risked business with strong inventory, continued focus on capital efficiency and shareholder returns while maintaining flexibility by strengthening liquidity and reducing leverage.
Sign In
Buy OVV